Receiving a “Stand Up to Cancer Day” email gave me the strength to support a friend through her darkest cancer days.

Dr. Josh Sabari and Max Doppelt explore challenges in trial enrollment and the potential of emerging therapies to offer hope ...

That is what standing up to cancer means to me: not just surviving, but living fully, deeply, and purposefully, showing the ...

For patients with advanced non-small cell lung cancer who progressed on two or more prior regimens, THIO with Libtayo ...

Chemotherapy can trigger early menopause, while strategies and new data on pausing therapy may help women protect fertility ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist.

Dr. Thomas Jankowski explained that THIO, a telomerase inhibitor, is being studied with Libtayo to help overcome resistance in advanced lung cancer.

Early-stage gynecologic cancer is confined to its original site and often treatable; diagnosis, surgery, and new therapies improve outcomes.

Perioperative immunotherapy for the treatment of non-small cell lung cancer is starting to exhibit survival benefits among ...

Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer ...

This guide is designed to help you understand liver cancer and equip you with the right questions to ask your medical team.

The FDA has accepted a new drug application for relacorilant as a treatment for patients with platinum-resistant ovarian ...